Online Only Articles

MYD88 mutated and wild-type Waldenström’s Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in CXCR4

Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA
Department of Oncologic Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA;Department of Pathology, Brigham & Women’s Hospital, Boston, MA, USA
Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy;Department of Molecular Medicine, University of Pavia, Italy
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Bing Center for Waldenström’s Macroglobulinemia, Dana-Farber Cancer Institute, USA;Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Vol. 103 No. 9 (2018): September, 2018 https://doi.org/10.3324/haematol.2018.190181